BBTX Conversion Disclosure
Jeggle Helmut Wolfgang · SEC Form 4 · Filed Nov 2, 2026
Conversion
Calculated transaction value
$0
Jeggle Helmut Wolfgang Director / Ten Percent Owner
BBTX
Transaction date
Nov 2, 2026
Public filing date
Nov 2, 2026
Filing lag
Filed same day
BBTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series A-1 Preferred Stock on Common Stock
- Quantity / price
- 1,473,775 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001982614-26-000004
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$6M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bambusa Therapeutics, Inc. BBTX | Conversion | Nov 2, 2026 | Not reported |
| Bambusa Therapeutics, Inc. BBTX | Conversion | Nov 2, 2026 | $0 |
| Bambusa Therapeutics, Inc. BBTX | Conversion | Nov 2, 2026 | $0 |
| Bambusa Therapeutics, Inc. BBTX Current | Conversion | Nov 2, 2026 | $0 |
| Bambusa Therapeutics, Inc. BBTX | Buy | Nov 2, 2026 | $6M |